É. Rouveix

2.0k total citations
77 papers, 948 citations indexed

About

É. Rouveix is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, É. Rouveix has authored 77 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 39 papers in Epidemiology and 17 papers in Virology. Recurrent topics in É. Rouveix's work include HIV/AIDS Research and Interventions (20 papers), HIV Research and Treatment (14 papers) and HIV/AIDS drug development and treatment (11 papers). É. Rouveix is often cited by papers focused on HIV/AIDS Research and Interventions (20 papers), HIV Research and Treatment (14 papers) and HIV/AIDS drug development and treatment (11 papers). É. Rouveix collaborates with scholars based in France, United States and Belgium. É. Rouveix's co-authors include B. Régnier, S Witchitz, F Fraisse, Caroline Dupont, Dominique Costagliola, Pierre de Truchis, Alain Beauchet, Philippe Aegerter, Laurence Weiss and Philippe Saïag and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

É. Rouveix

71 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
É. Rouveix France 15 464 458 184 160 123 77 948
F. Raffi France 21 721 1.6× 734 1.6× 220 1.2× 144 0.9× 142 1.2× 71 1.5k
Claudio Angeletti Italy 21 736 1.6× 585 1.3× 365 2.0× 129 0.8× 138 1.1× 50 1.2k
Emílio Letang Spain 23 872 1.9× 688 1.5× 252 1.4× 121 0.8× 136 1.1× 61 1.4k
B Gazzard United Kingdom 22 647 1.4× 477 1.0× 319 1.7× 200 1.3× 220 1.8× 49 1.4k
Chris Taylor United Kingdom 17 549 1.2× 559 1.2× 149 0.8× 53 0.3× 237 1.9× 49 1.2k
Frederik Neess Engsig Denmark 16 543 1.2× 457 1.0× 363 2.0× 247 1.5× 355 2.9× 33 1.1k
Christian Manzardo Spain 18 607 1.3× 398 0.9× 368 2.0× 51 0.3× 167 1.4× 54 959
Manuel Márquez Spain 23 673 1.5× 819 1.8× 246 1.3× 128 0.8× 325 2.6× 88 1.4k
Javier Martínez‐Sanz Spain 18 401 0.9× 425 0.9× 112 0.6× 80 0.5× 98 0.8× 82 903
Katsuji Teruya Japan 23 999 2.2× 773 1.7× 316 1.7× 223 1.4× 325 2.6× 116 1.8k

Countries citing papers authored by É. Rouveix

Since Specialization
Citations

This map shows the geographic impact of É. Rouveix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Rouveix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Rouveix more than expected).

Fields of papers citing papers by É. Rouveix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Rouveix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Rouveix. The network helps show where É. Rouveix may publish in the future.

Co-authorship network of co-authors of É. Rouveix

This figure shows the co-authorship network connecting the top 25 collaborators of É. Rouveix. A scholar is included among the top collaborators of É. Rouveix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Rouveix. É. Rouveix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greffe, S., et al.. (2023). MPOX de 1960 à 2022. Du Monkeypox au Mpox. 4(4). 294–301.
3.
Bouvet, E., D. Abiteboul, Isabelle Lolom, et al.. (2020). Contexte de contamination des professionnels de santé par la COVID-19 : résultats préliminaires. Médecine et Maladies Infectieuses. 50(6). S71–S71. 2 indexed citations
4.
Brunet, Jean‐Baptiste, et al.. (2020). Context of health care workers contamination during the first SARS-CoV-2 epidemic wave in France. 35. 690–695. 2 indexed citations
5.
Rouveix, É., E. Mortier, Alain Beauchet, et al.. (2016). Analyse des motivations du choix des antirétroviraux (ARV) prescrits chez des patients infectés par le VIH (PVVIH) naïfs. La Revue de Médecine Interne. 37(12). 796–801. 4 indexed citations
6.
Greffe, S., et al.. (2015). HSV-2 meningoencephalitis in an immunocompetent young man: what is the pathogenesis and what is the treatment?. Journal of Clinical Virology. 69. 40–43. 4 indexed citations
7.
Rouveix, É., et al.. (2014). Management of accidental exposure to HIV: The COREVIH 2011 activity report. Médecine et Maladies Infectieuses. 44(3). 112–116. 2 indexed citations
8.
Lacombe, Jean‐Marc, François Boué, Sophie Grabar, et al.. (2012). Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy. AIDS. 27(4). 635–643. 17 indexed citations
9.
Rouveix, É., et al.. (2012). Streptococcus pneumoniae vaccinal coverage in hospitalized elderly patients in France. Médecine et Maladies Infectieuses. 43(1). 22–27. 11 indexed citations
10.
Lanoy, Émilie, Marguerite Guiguet, M. Bentata, et al.. (2011). Survival after neuroAIDS. Neurology. 76(7). 644–651. 29 indexed citations
11.
Truchis, Pierre de, et al.. (2010). Family nutritional support improves survival, immune restoration and adherence in HIV patients receiving ART in developing country.. PubMed. 19(1). 68–75. 34 indexed citations
12.
Potard, Valérie, et al.. (2009). Trends in Post-Infection CD4 Cell Counts and Plasma HIV-1 RNA Levels in HIV-1–Infected Patients in France Between 1997 and 2005. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(3). 422–426. 12 indexed citations
13.
Giraud, Violaine, et al.. (2009). Syndrome de Cushing induit par la prise concomitante de fluticasone et de ritonavir. Revue des Maladies Respiratoires. 26(7). 779–782. 7 indexed citations
14.
Dupont, Caroline, et al.. (2001). Neurotoxicité à la sulfasalazine. 152(4). 283–284. 2 indexed citations
15.
Dupont, Caroline, Alain Beauchet, Philippe Aegerter, et al.. (2000). Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS. 14(8). 987–993. 87 indexed citations
16.
Dupont, Chloé, et al.. (1996). [Staphylococcus lugdunensis endocarditis. A new case].. PubMed. 147(5). 374–5. 2 indexed citations
17.
Judet, Olivia, et al.. (1989). [A classical but unknown cause of peritoneal effusion disclosed by echography. Typhoid fever].. PubMed. 70(6-7). 419–21. 2 indexed citations
18.
Bandt, Michel De, et al.. (1988). [Joint manifestations and HIV infections].. PubMed. 139(7). 516–22. 2 indexed citations
19.
Witchitz, S, et al.. (1984). Surgery in infective endocarditis. European Heart Journal. 5(suppl C). 87–91. 6 indexed citations
20.
Witchitz, S, et al.. (1983). Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.. PubMed. 62(3). 1283–7. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026